BK21 FOUR Team and Integrated Research Institute for Drug Development, College of Pharmacy, Dongguk University, Gyeonggi 10326, Republic of Korea.
Chong Kun Dang Research Institute (Hyojong), Gyeonggi 16995, Republic of Korea.
Int J Pharm. 2021 Feb 15;595:120257. doi: 10.1016/j.ijpharm.2021.120257. Epub 2021 Jan 22.
Main purpose was to evaluate the applicability of a 3D-printer equipped with a hot-melt pneumatic dispenser as a single-step process to prepare tablet dosage forms. Dutasteride, a poorly water-soluble drug, was selected as a model drug. Soluplus®, Kollidon® VA 64, Eudragit® E PO, and hydroxypropyl cellulose (HPC) were premixed as bulking agents prior to printing. Differential scanning calorimetry (DSC), powder X-ray diffraction (PXRD), and thermogravimetric analysis (TGA) were utilized to evaluate the physicochemical properties of the 3D-printed tablets. Moreover, different geometries were designed to correlate the surface area/volume (SA/V) of the tablets with respect to their release profiles. As a result, printed dutasteride was confirmed to be in an amorphous state and not recrystallized even after the accelerated storage stability. Out of the four bulking agents, Kollidon® VA 64, enhanced the dissolution of the printed dutasteride, reaching above 80% within 15 min. These results suggest that the hot-melt pneumatic dispenser was efficient in converting the solid state into an amorphous state, which significantly enhanced the dissolution. On the other hand, the tube-shaped 3D-printed tablet exhibited the fastest drug dissolution profile, which had the highest SA/V ratio in comparison to the cube, hemisphere, and pyramid shapes. These results confirm the dependency of the drug dissolution rate not only on its crystallinity but also on the surface area of the 3D-printed tablet. Therefore, a 3D-printer equipped with a hot-melt pneumatic dispenser possesses useful applicability in enhancing drug dissolution, especially for poorly water-soluble drugs, in a single-step process.
主要目的是评估配备热熔气动分配器的 3D 打印机作为单一工艺制备片剂剂型的适用性。选择难溶性药物度他雄胺作为模型药物。在打印前,将共聚维酮(Soluplus®)、共聚维酮(Kollidon® VA 64)、乙烯基吡咯烷酮均聚物(Eudragit® E PO)和羟丙基纤维素(HPC)预混合作为填充剂。利用差示扫描量热法(DSC)、粉末 X 射线衍射(PXRD)和热重分析(TGA)来评估 3D 打印片剂的物理化学性质。此外,设计了不同的几何形状,将片剂的表面积/体积(SA/V)与释放曲线相关联。结果表明,打印的度他雄胺处于无定形态,即使在加速稳定性存储后也没有重结晶。在这四种填充剂中,共聚维酮(Kollidon® VA 64)增强了打印度他雄胺的溶解,在 15 分钟内达到 80%以上。这些结果表明,热熔气动分配器有效地将固体状态转化为无定形态,从而显著提高了溶解度。另一方面,管状 3D 打印片剂表现出最快的药物溶解曲线,与立方体、半球形和金字塔形相比,其具有最高的 SA/V 比。这些结果证实,药物溶解速率不仅取决于其结晶度,还取决于 3D 打印片剂的表面积。因此,配备热熔气动分配器的 3D 打印机在单一工艺中具有增强药物溶解度的有用适用性,特别是对于难溶性药物。